Immunogenetics of systemic lupus erythematosus: A comprehensive review.
Our understanding of the genetic basis of systemic lupus erythematosus has progressed rapidly in recent years. While many genetic polymorphisms have been associated with disease susceptibility, the next major step involves integrating these genetic polymorphisms into the molecular mechanisms and cellular immunology of the human disease. In this review, we summarize some recent work in this area, including the genetics of the type I IFN response in SLE, including polygenic and monogenic factors, as well as epigenetic influences. Contributions of both HLA and non-HLA polymorphisms to the complex genetics of SLE are reviewed. We also review recent reports of specific gene deficits leading to monogenic SLE-like syndromes. The molecular functions of common SLE-risk variants are reviewed in depth, including regulatory variations in promoter and enhancer elements and coding-change polymorphisms, and studies which are beginning to define the molecular and cellular functions of these polymorphisms in the immune system. We discuss epigenetic influences on lupus, with an emphasis on micro-RNA expression and binding, as well as epigenetic modifications that regulate the expression levels of various genes involved in SLE pathogenesis and the ways epigenetic marks modify SLE susceptibility genes. The work summarized in this review provides a fascinating window into the biology and molecular mechanisms of human SLE. Understanding the functional mechanisms of causal genetic variants underlying the human disease greatly facilitates our ability to translate genetic associations toward personalized care, and may identify new therapeutic targets relevant to human SLE disease mechanisms.
Division of Rheumatology, Department of Immunology, Mayo Clinic, Rochester, MN, USA.
Yogita
Y
Ghodke-Puranik
Division of Rheumatology, Department of Immunology, Mayo Clinic, Rochester, MN, USA. Electronic address: Niewold.Timothy@mayo.edu.
Timothy B
TB
Niewold
D000818:Animals; D001327:Autoimmune Diseases / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D044127:Epigenesis, Genetic; D056426:Genetic Loci; D020022:Genetic Predisposition to Disease; D006801:Humans; D007125:Immunogenetics; D007370:Interferon Type I / Q000235:genetics / Q000378:metabolism; D008180:Lupus Erythematosus, Systemic / Q000235:genetics* / Q000276:immunology* / Q000378:metabolism; D008285:Major Histocompatibility Complex / Q000235:genetics / Q000276:immunology; D020412:Multifactorial Inheritance; D016366:Open Reading Frames; D011110:Polymorphism, Genetic; D012045:Regulatory Sequences, Nucleic Acid; D015398:Signal Transduction
D007370:Interferon Type I
Autoimmune diseases; Genetics; Interferon; Systemic lupus erythematosus